Testing Companies Pay Almost $1.75 Million to Settle Allegations They Billed Court-Ordered Drug Tests to Healthcare Programs

Two drug testing businesses have agreed to collectively pay nearly $1.75 million to settle allegations they improperly billed non-medical tests to Medicare and Medicaid.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year
